c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate Update
GlobeNewswire Inc. | Oct 28, 2026 7:00 AM EDT
TUDRIQEV first delivered to patients for advanced melanoma on October 6th
Read original article